抗ヒトCD44 v9 抗体
抗マウス CD44 v10-e16 抗体 ‐ 参考文献

« 抗ヒトCD44 v9 抗体 / 抗マウス CD44 v10-e16 抗体

1. 1. Yoshida GJ, Saya H., Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation. Biochem Biophys Res Commun. 2014 Jan 10;443(2):622-7. PMID: 24333422

2. 2. Yoshida GJ, Saya H, Zouboulis CC., Three-dimensional culture of sebaceous gland cells revealing the role of prostaglandin E2-induced activation of canonical Wnt signaling. Biochem Biophys Res Commun. 2013 Sep 6;438(4):640-6. PMID: 23948691

3. 3. Nagano O, Okazaki S, Saya H., Redox regulation in stem-like cancer cells by CD44 variant isoforms. Oncogene. 2013 Jan 21., 1-8. PMID:23334333

4. 4. Yoshikawa M, Tsuchihashi K, Ishimoto T, Yae T, Motohara T, Sugihara E, Onishi N, Masuko T, Yoshizawa K, Kawashiri S, Mukai M, Asoda S, Kawana H, Nakagawa T, Saya H, Nagano O., xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma. Cancer Res. 2013 Mar 15;73(6):1855-66. PMID: 23319806

5. 5. Tsugawa H, Suzuki H, Saya H, Hatakeyama M, Hirayama T, Hirata K, Nagano O, Matsuzaki J, Hibi T., Reactive
   oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe. 2012 Dec 13;12(6):764-77. PMID: 23245321

6. 6. Yae T, Tsuchihashi K, Ishimoto T, Motohara T, Yoshikawa M, Yoshida GJ, Wada T, Masuko T, Mogushi K, Tanaka H, Osawa T, Kanki Y, Minami T, Aburatani H, Ohmura M, Kubo A, Suematsu M, Takahashi K, Saya H, Nagano O., Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Nat Commun. 2012 Jun 6;3:883. PMID: 22673910

7. 7. Masuko K, Okazaki S, Satoh M, Tanaka G, Ikeda T, Torii R, Ueda E, Nakano T, Danbayashi M, Tsuruoka T, Ohno Y, Yagi H, Yabe N, Yoshida H, Tahara T, Kataoka S, Oshino T, Shindo T, Niwa S, Ishimoto T, Baba H, Hashimoto Y, Saya H, Masuko T., Anti-Tumor Effect against Human Cancer Xenografts by a Fully Human Monoclonal Antibody to a Variant 8Epitope of CD44R1 Expressed on Cancer Stem Cells. PLoS One. 2012;7(1):e29728. PMID: 22272243

8. 8. Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, Masuko T, Shimizu T, Ishikawa T, Kai K, Takahashi E, Imamura Y, Baba Y, Ohmura M, Suematsu M, Baba H, Saya H., CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell. 2011 Mar 8;19(3):387-400. PMID : 21397861

9. 9. Masuko T, Ohno Y, Masuko K, Yagi H, Uejima S, Takechi M, Hashimoto Y., Towards therapeutic antibodies to membrane oncoproteins by a robust strategy using rats immunized with transfectants expressing target molecules fused to green fluorescent protein. Cancer Sci. 2011 Jan;102(1):25-35. PMID: 21040216

10. 10. Ishimoto T, Oshima H, Oshima M, Kai K, Torii R, Masuko T, Baba H, Saya H, Nagano O., CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis. Cancer Sci. 2010 Mar;101(3):673-8. PMID: 20028388

11. 11. Lo M, Wang YZ, Gout PW., The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases, J Cell Physiol. 2008 Jun;215(3):593-602. PMID: 18181196

12. 12. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM., Identification of pancreatic cancer stem cells. Cancer Res. 2007 Feb 1;67(3):1030-7. PMID: 17283135

13. 13. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF., Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63  PMID: 17548814

14. 14. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE., Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):973-8. PMID: 17210912

15. 15. Anne T. Collins,1 Paul A. Berry,1 Catherine Hyde,1 Michael J. Stower,2 and Norman J. Maitland1, Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005 Dec 1;65(23):10946-51.
    PMID: 16322242

16. 16. Huang Y, Dai Z, Barbacioru C, Sadee W., Cystine-Glutamate Transporter SLC7A11 in Cancer Chemosensitivity and Chemoresistance, Cancer Res. 2005 Aug 15;65(16):7446-54  PMID: 16103098

17. 17. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF., Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8. PMID: 12629218

18. 18. Ponta H, Sherman L, Herrlich PA., CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 2003 Jan;4(1):33-45. PMID: 12511867

19. 19.Tanabe KK, Ellis LM, Saya H., Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet. 1993 Mar 20;341(8847):725-6. PMID: 8095628

20. 20. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B., CD44 is the principal cell surface receptor for hyaluronate. Cell, Vol. 61. 1303-1313, June 29, 1990, PMID: 1694723

※  表示価格について